Zambia Ending AIDS Campaign Materials

7 July 2022

JSI’s USAID DISCOVER-Health Project contributes towards HIV epidemic control in Zambia and has produced a number of PrEP campaign materials. See below!

Tools

Videos

Introduction to Zambia Ending AIDS

The Zambia Ending AIDS campaign is all about taking control of your sexual health. Knowing your HIV status is important and so is living your life free from judgement and stigma. There is an HIV prevention or treatment option out there that suits you and your lifestyle – and we can help you find it! This video is an introduction to how the campaign was created.

What is HIV risk?

The first step to safeguarding your health is by knowing your HIV status. Whatever result you get, there is a way to manage it, be healthy, live your life, and crucially be safer in the knowledge you gain. So, how do you know if you’re at risk of contracting HIV? This video outlines the different practices that may put you at risk and ways to protect yourself by choosing an HIV prevention plan that suits your life.

Asking to Use a Condom

Condoms offer all-in-one protection from HIV, sexually transmitted infections (STIs) and pregnancy. They’re cheap and readily available from most pharmacies and health centers. Asking to use a condom though isn’t always so easy, right? Worried you will get a bad reaction from your partner or just not sure how to say it? This video gives you tips on how to start that conversation. Remember, pleasure is important, but so is protection. Luckily, condoms can offer both!

How to Take PrEP

Have you heard about PrEP? It’s a new daily pill to help prevent HIV. It’s safe, discreet and puts you in control of protecting yourself. It’s for people who are HIV negative but are at risk of contracting. So, could you be eligible for it? This video helps you find out more about PrEP and if it could be right for you.

Living with HIV

What’s it like living with HIV? From the moment you find out, to getting on treatment, and planning for your future. HIV is like any other disease. It’s important to remember you can live a long and happy life. There will be challenges, like dealing with stigma and judgement, but this video shows why the power lies with you and how you can respond to your status with resilience and positivity.

Guide to Providing PrEP

Calling all healthcare providers! This video is for you, as we outline some top tips and guidance on prescribing PrEP. We want to empower you with the information you need about PrEP, inform you on how best to counsel your client on what’s right for them, and support them in a non-judgmental manner.

What is PrEP?

You prepare yourself for the weather, you prepare yourself for a test, you prepare for the future…so why not prepare for safer sex? PrEP is a new daily pill to help prevent HIV. It’s safe, discreet and puts you in control of protecting yourself. It’s for people who are HIV negative but are at risk of contracting. This video shares more information about what PrEP is and how to take it.

Raising Awareness

There’s a new way to prevent HIV and it’s called PrEP! It’s a daily pill that is safe and discreet to take. If you’re HIV negative and are at risk of contracting, PrEP could be what you need to protect yourself. Don’t just take it from us, check out what your favorite celebrities – Bombshell, Bobby East, Slap-Dee and Mwaka Mugala – have to say about it!

Featured Resources

Document

Global Acute HIV Infection Algorithm Job Aids for Providers

This tool can assist providers in assessing acute HIV infection (AHI) in clients using oral PrEP, PrEP ring, and CAB PrEP by offering guidance through three steps: HIV testing, recent exposure to HIV assessment, and AHI assessment. Providers are encouraged to use clinical judgement and defer to national guidance as needed.

Document

Daily Oral PrEP, PrEP Ring, and CAB PrEP Template Guidelines (Spanish)

The intent of this document is to provide adaptable guidelines to support the development and adoption of national guidelines that align with World Health Organization (WHO) pre-exposure prophylaxis (PrEP) recommendations and guidance, including those for tenofovir disoproxil fumarate (TDF)-based oral PrEP, the monthly dapivirine vaginal ring (“PrEP ring” or “the ring”), and injectable cabotegravir (CAB…

Document

HIV Prevention User Journey Tool

The HIV Prevention Journey Tool was developed to support adolescent girls and young women to explore methods that would align with their lifestyle, needs and personal preferences; and support healthcare providers to provide informed counseling based on client needs. The digital tool, which has been optimized for use on mobile devices, can be accessed here.…

Spreadsheet

2024 Q3 Global PrEP Tracker

AVAC’s Global PrEP Tracker offers two views on PrEP uptake around the world. Visit data.prepwatch.org for a dynamic map-based tool to explore trends in oral PrEP use globally as countries introduce and scale up PrEP programs. For insights on the full scope of PrEP use around the world, the PrEP Tracker as a spreadsheet offers…

Document

Oral PrEP, PrEP Ring, and CAB PrEP Template Guidelines (English)

External Link

Pre-Exposure Prophylaxis Implementation Gaps among People Vulnerable to HIV Acquisition: A cross-sectional analysis in two communities in western Kenya, 2021–2023

This article, from Journal of the International AIDS Society, examines PrEP awareness, uptake, and persistence among participants enrolling into an HIV incidence cohort in Kenya.

External Link

Initiation and Continued Use of Oral Pre-Exposure Prophylaxis among Pregnant and Postpartum Women in South Africa (PrEP-PP): A demonstration cohort study

This article from The Lancet HIV describes the results of a demonstration study in South Africa, PrEP-PP, to integrate oral PrEP provision into public clinics offering antenatal and postnatal care to pregnant and lactating people.

External Link

Acceptability of Six-Monthly PrEP Dispensing Supported with Interim HIV Self-Testing to Simplify PrEP Delivery in Kenya: Findings from qualitative research

This article from BMC Health Services Research discusses the results of a pilot in Kenya to explore the acceptability of dispensing PrEP twice a year, with interim HIV self-testing, versus quarterly, with clinic-based HIV testing.

External Link

Dynamic Choice HIV Prevention with Cabotegravir Long-acting Injectable in Rural Uganda and Kenya: A randomised trial extension

This article from The Lancet HIV discusses the results of the SEARCH dynamic choice study conducted in Kenya and Uganda, comparing outcomes between one group offered a choice between oral PrEP, post-exposure prophylaxis, and cabotegravir for PrEP, and a second group receiving the standard of care.

External Link

Adolescent Girls and Young Women Overcoming Adherence Challenges with Vaginal and Oral PrEP Use: A longitudinal qualitative study from a crossover trial in South Africa, Uganda, and Zimbabwe

This article from AIDS and Behavior explores South African, Ugandan, and Zimbabwean adolescent girls and young women’s experiences in a crossover trial of two HIV prevention products: daily oral PrEP and a monthly dapivirine vaginal ring.